PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
33.44 - 34.57
31.40 - 61.90
7.61M / 5.95M (Avg.)
-152.73 | -0.22
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
7.31%
Revenue growth under 50% of MDB's 15.07%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
9.29%
Gross profit growth at 50-75% of MDB's 17.58%. Martin Whitman would question if cost structure or brand is lagging.
8.01%
EBIT growth below 50% of MDB's 36.40%. Michael Burry would suspect deeper competitive or cost structure issues.
8.01%
Operating income growth under 50% of MDB's 28.51%. Michael Burry would be concerned about deeper cost or sales issues.
11.62%
Net income growth under 50% of MDB's 30.69%. Michael Burry would suspect the firm is falling well behind a key competitor.
15.38%
EPS growth under 50% of MDB's 31.17%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
15.38%
Diluted EPS growth under 50% of MDB's 31.17%. Michael Burry would worry about an eroding competitive position or excessive dilution.
1.02%
Share count expansion well above MDB's 0.99%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
1.02%
Diluted share count expanding well above MDB's 0.99%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
-26.15%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-40.72%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
0.52%
10Y revenue/share CAGR under 50% of MDB's 197.92%. Michael Burry would suspect a lasting competitive disadvantage.
0.52%
5Y revenue/share CAGR under 50% of MDB's 432.37%. Michael Burry would suspect a significant competitive gap or product weakness.
0.52%
3Y revenue/share CAGR under 50% of MDB's 152.50%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
107.97%
10Y OCF/share CAGR above 1.5x MDB's 65.22%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
107.97%
Positive OCF/share growth while MDB is negative. John Neff might see a comparative advantage in operational cash viability.
107.97%
Positive 3Y OCF/share CAGR while MDB is negative. John Neff might see a big short-term edge in operational efficiency.
11.45%
Below 50% of MDB's 73.76%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
11.45%
5Y net income/share CAGR at 75-90% of MDB's 13.10%. Bill Ackman would advocate improvements to match competitor’s profit expansion.
11.45%
Below 50% of MDB's 51.99%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
12.54%
AR growth is negative/stable vs. MDB's 28.74%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
-32.82%
Inventory is declining while MDB stands at 1.54%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
2.76%
Similar asset growth to MDB's 2.62%. Walter Schloss finds parallel expansions or investment rates.
0.47%
Under 50% of MDB's 10.59%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
0.49%
Debt growth far above MDB's 0.26%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
5.97%
R&D growth drastically higher vs. MDB's 7.36%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
2.44%
SG&A declining or stable vs. MDB's 8.75%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.